|
|
|
Kidney Disease Clinical Trials |
|
Thank you for your interest in clinical trials for Kidney Disease
Please click "Search" to find Kidney Disease clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 1 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- “Nephrology Research BioBank” - NCT00381121-48109
Conditions: Chronic Kidney Disease
Location: Ann Arbor, MI
- 20070360 Incident Dialysis - NCT00803712-
Conditions: Secondary Hyperparathyroidism - Chronic Kidney Disease
Location: Chesapeake, VA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lakewood, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-01107A
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Springfield, MA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-01107B
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Springfield, MA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-02720
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Fall River, MA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-02904
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Providence, RI
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-04210
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Auburn, ME
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-07202
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Elizabeth, NJ
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-08009
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Berlin, NJ
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-08844
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hillsborough, NJ
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-11021
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Great Neck, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-11042
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lake Success, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-11355
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Flushing, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-14221
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Williamsville, NY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-15904
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Johnstown, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-16635
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Duncansville, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-16684
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tipton, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-16933
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mansfield, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-17015
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Carlisle, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-17740
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Jersey Shore, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-18103
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Allentown, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-18944
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Perkasie, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-18974
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Warminster, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-19107
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Philadelphia, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-19141
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Philadelphia, PA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-20852
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Rockville, MD
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-21015
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Bel Air, MD
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-21208
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Pikesville, MD
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28112
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Monroe, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28208
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charlotte, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28277
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charlotte, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28557
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Morehead City, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-28626
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charlotte, NC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29209
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Columbia, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29412
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Charleston, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29464
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mount Pleasant, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29485
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Summerville, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-29605
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Greenville, SC
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30024
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Suwanee, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30060
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Marietta, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30076
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Roswell, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30331
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Atlanta, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-30338
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Dunwoody, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-31217
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Macon, GA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32117
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Daytona Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32610
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Gainesville, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32714
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Ormond Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32779
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Longwood, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-32804
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Orlando, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33028
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Pembroke Pines, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33065
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Coral Springs, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33313
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lauderdale Lakes, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33401
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: West Palm Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33472
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Boynton Beach, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33563
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Plant City, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33607
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tampa, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33756
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Clearwater, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33880
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Winter Haven, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-33952
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Port Charlotte, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-34652
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: New Port Richey, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-34667
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hudson, FL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-35242
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Birmingham, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-35758
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Madison, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-35801
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Huntsville, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-36106
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Montgomery, AL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-37130
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Murfreesboro, TN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-37205
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Nashville, TN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-38654
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Olive Branch, MS
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-42003
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Paducah, KY
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-43215
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Columbus, OH
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-45040
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mason, OH
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-45267
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Cincinnati, OH
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-46544
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Mishawaka, IN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-48073
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Royal Oak, MI
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-51505
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Council Bluffs, IA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-55430
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Brooklyn Center, MN
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-60504
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Aurora, IL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-61603
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Peoria, IL
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-70121
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: New Orleans, LA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-71101
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Shreveport, LA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-71901
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Hot Springs, AR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-73103
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Oklahoma City, OK
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-74136
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tulsa, OK
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-75251
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Dallas, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-76104
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Fort Worth, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-77005
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Houston, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-77074
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Houston, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-78207
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: San Antonio, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-78224
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: San Antonio, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-78539
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Edinburg, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-79410
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lubbock, TX
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-80031
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Westminster, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-80214
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Lakewood, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-80260
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Thorton, CO
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-84124
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Salt Lake City, UT
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-84403
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Ogden, UT
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90048
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Los Angeles, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90073
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Los Angeles, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90650
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Norwalk, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-90806
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Long Beach, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91204
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Glendale, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91307
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: West Hills, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91910
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Chula Vista, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-91942
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: La Mesa, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-92123
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: San Diego, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-92505
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Riverside, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-92708
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Fountain Valley, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-93065
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Simi Valley, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-95661
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Roseville, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-95825
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Sacramento, CA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-97210
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Portland, OR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-97504
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Medford, OR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-97701
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Bend, OR
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-98335
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Gig Harbor, WA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-98405
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Tacoma, WA
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease - NCT00680017-98665
Conditions: Dyslipidemias - Coronary Heart Disease - Kidney Disease
Location: Vancouver, WA
- 8-week Pilot Study of Relaxation for Weight Loss in Adults With Chronic Kidney Disease - NCT00944138-60141
Conditions: Obesity
Location: Hines, IL
- A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease - NCT00830037-46202
Conditions: Chronic Kidney Disease - Iron-Deficiency Anemia
Location: Indianapolis, IN
- A Comparative Study to Assess the Differences in Kidney Structure and Function Between Young Kidney Donors Aged 18 to 45 Years and Older Kidney Donors Aged 55 Years and Above Before and After Kidney Donation for Transplantation. - NCT00846729-94305
Conditions: Kidney Diseases
Location: Stanford, CA
- A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD - NCT00785629-80230
Conditions: Chronic Kidney Disease
Location: Denver, CO
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer - NCT00816686-10021
Conditions: Carcinoma, Renal Cell - Kidney Neoplasms - Kidney Diseases
Location: New York, NY
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer - NCT00816686-19111
Conditions: Carcinoma, Renal Cell - Kidney Neoplasms - Kidney Diseases
Location: Philadelphia, PA
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer - NCT00816686-21231
Conditions: Carcinoma, Renal Cell - Kidney Neoplasms - Kidney Diseases
Location: Baltimore, MD
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-01104
Conditions: Chronic Kidney Disease
Location: Springfield, MA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-02115
Conditions: Chronic Kidney Disease
Location: Boston, MA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-04102
Conditions: Chronic Kidney Disease
Location: Portland, ME
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-10065
Conditions: Chronic Kidney Disease
Location: New York, NY
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-23507
Conditions: Chronic Kidney Disease
Location: Norfolk, VA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-27710
Conditions: Chronic Kidney Disease
Location: Durham, NC
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-45267
Conditions: Chronic Kidney Disease
Location: Cincinnati, OH
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-46202
Conditions: Chronic Kidney Disease
Location: Indianapolis, IN
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-52242
Conditions: Chronic Kidney Disease
Location: Iowa City, IA
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-63110
Conditions: Chronic Kidney Disease
Location: St. Louis, MO
- A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients - NCT00679991-77030
Conditions: Chronic Kidney Disease
Location: Houston, TX
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-14215
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Buffalo, NY
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-18103
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Allentown, PA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-20852
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Rockville, MD
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-22205
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Arlington, VA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-27834
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Greenville, NC
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-28557
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Morehead City, NC
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-33028A
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Pembroke Pines, FL
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-33028B
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Pembroke Pines, FL
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-34608
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Spring Hill, FL
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-68131
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Omaha, NE
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-78229A
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: San Antonio, TX
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-78229B
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: San Antonio, TX
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-78229C
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: San Antonio, TX
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-85284
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Tempe, AZ
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-90022
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Los Angeles, CA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-90048
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Los Angeles, CA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-90603
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Whittier, CA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-91773
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: San Dimas, CA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-91910
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Chula Vista, CA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-91942
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: La Mesa, CA
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors - NCT00920764-95991
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Yuba City, CA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-01107
Conditions: Anemia - Chronic Kidney Disease
Location: Springfield, MA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-11355
Conditions: Anemia - Chronic Kidney Disease
Location: Flushing, NY
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-11501
Conditions: Anemia - Chronic Kidney Disease
Location: Mineola, NY
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-29118
Conditions: Anemia - Chronic Kidney Disease
Location: Orangeburg, SC
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-33028
Conditions: Anemia - Chronic Kidney Disease
Location: Pembroke Pines, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-33173
Conditions: Anemia - Chronic Kidney Disease
Location: Miami, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-33313
Conditions: Anemia - Chronic Kidney Disease
Location: Lauderdale Lakes, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-34108
Conditions: Anemia - Chronic Kidney Disease
Location: Naples, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-37205
Conditions: Anemia - Chronic Kidney Disease
Location: Nashville, TN
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-46545
Conditions: Anemia - Chronic Kidney Disease
Location: Mishawaka, IN
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-61603
Conditions: Anemia - Chronic Kidney Disease
Location: Peoria, IL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-76015
Conditions: Anemia - Chronic Kidney Disease
Location: Arlington, TX
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-77054
Conditions: Anemia - Chronic Kidney Disease
Location: Houston, TX
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-78215
Conditions: Anemia - Chronic Kidney Disease
Location: San Antobio, TX
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-83642
Conditions: Anemia - Chronic Kidney Disease
Location: Meridian, ID
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-90022
Conditions: Anemia - Chronic Kidney Disease
Location: Los Angeles, CA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-90603
Conditions: Anemia - Chronic Kidney Disease
Location: Whittier, CA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-92123
Conditions: Anemia - Chronic Kidney Disease
Location: San Diego, CA
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-10065
Conditions: Chronic Kidney Disease
Location: New York, NY
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-23507
Conditions: Chronic Kidney Disease
Location: Norfolk, VA
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-27710
Conditions: Chronic Kidney Disease
Location: Durham, NC
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-45267
Conditions: Chronic Kidney Disease
Location: Cincinnati, OH
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-46202
Conditions: Chronic Kidney Disease
Location: Indianapolis, IN
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-48507
Conditions: Chronic Kidney Disease
Location: Flint, MI
- A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease - NCT01001351-78205
Conditions: Chronic Kidney Disease
Location: San Antonio, TX
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-11355
Conditions: Anemia - Chronic Kidney Disease
Location: Flushing, NY
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-14221
Conditions: Anemia - Chronic Kidney Disease
Location: Williamsville, NY
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-22030
Conditions: Anemia - Chronic Kidney Disease
Location: Farifax, VA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-23116
Conditions: Anemia - Chronic Kidney Disease
Location: Mechanicsville,, VA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-33028
Conditions: Anemia - Chronic Kidney Disease
Location: Pembroke Pines, FL
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-33156
Conditions: Anemia - Chronic Kidney Disease
Location: Pinecrest, FL
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-43606
Conditions: Anemia - Chronic Kidney Disease
Location: Toledo, OH
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-45267
Conditions: Anemia - Chronic Kidney Disease
Location: Cincinnati, OH
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-60031
Conditions: Anemia - Chronic Kidney Disease
Location: Gurnee, IL
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-70723
Conditions: Anemia - Chronic Kidney Disease
Location: Paramount, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-76015
Conditions: Anemia - Chronic Kidney Disease
Location: Arlington, TX
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-77054
Conditions: Anemia - Chronic Kidney Disease
Location: Houston, TX
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-80002
Conditions: Anemia - Chronic Kidney Disease
Location: Arvada, CO
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-90022
Conditions: Anemia - Chronic Kidney Disease
Location: Los Angeles, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-90241
Conditions: Anemia - Chronic Kidney Disease
Location: Downey, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-91344
Conditions: Anemia - Chronic Kidney Disease
Location: Granada Hills, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-92123
Conditions: Anemia - Chronic Kidney Disease
Location: San Diego, CA
- ADMA Levels in End-Stage Renal Disease - NCT00350974-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide - NCT00356265-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Analysis of Calcium Balance in Chronic Kidney Disease - NCT00974532-80045
Conditions: Chronic Kidney Disease
Location: Denver, CO
- Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease - NCT00806676-21287
Conditions: Chronic Kidney Disease
Location: Baltimore, MD
- Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease - NCT00806676-30322
Conditions: Chronic Kidney Disease
Location: Atlanta, GA
- Assessing Novel Methods of Improving Patient Education of Nutrition - NCT00394576-53713
Conditions: Chronic Kidney Disease
Location: Madison, WI
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study - NCT00571909-55905
Conditions: Kidney, Polycystic, Autosomal Dominant
Location: Rochester, MN
- Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease - NCT00638222-02903
Conditions: Vascular Disease - Kidney Disease
Location: Providence, RI
- Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease - NCT00638222-43606
Conditions: Vascular Disease - Kidney Disease
Location: Toledo, OH
- Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients - NCT00660530-60612
Conditions: Hyperphosphatemia - Kidney Disease
Location: Chicago, IL
- Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study - NCT00921687-
Conditions: Chronic Renal Insufficiency
Location: Cleveland, OH
- Chronic Kidney Disease Antidepressant Sertraline Trial - NCT00946998-75216
Conditions: Chronic Kidney Disease - Depression
Location: Dallas, TX
- Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome - NCT00001456-20892
Conditions: Albinism - Intestinal Disease - Kidney Disease - Myocardial Disease - Pulmonary Fibrosis
Location: Bethesda, MD
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-48109
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Ann Arbor, MI
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-48201
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Detroit, MI
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-48236
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Detroit, MI
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center - NCT01016613-60612
Conditions: Chronic Kidney Disease - Glomerulopathy
Location: Chicago, IL
- Combination Chemotherapy and Radiation Therapy Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer - NCT00303719-55455
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Minneapolis, MN
- Comparison of Conventional Dialysis and the Allient System - NCT00788905-10003
Conditions: End Stage Renal Disease - Chronic Kidney Failure
Location: New York, NY
- Comparison of Conventional Dialysis and the Allient System - NCT00788905-10025
Conditions: End Stage Renal Disease - Chronic Kidney Failure
Location: New York, NY
- Comparison of Conventional Dialysis and the Allient System - NCT00788905-10128
Conditions: End Stage Renal Disease - Chronic Kidney Failure
Location: New York, NY
- Comparison of Dialysis Therapies on Cognitive Function - NCT00597103-94041A
Conditions: End Stage Renal Disease - Chronic Kidney Disease
Location: Mountain View, CA
- Comparison of Dialysis Therapies on Cognitive Function - NCT00597103-94041B
Conditions: End Stage Renal Disease - Chronic Kidney Disease
Location: Mountain View, CA
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-12866
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Saratoga Springs, NY
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-46202
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Indianapolis, IN
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-53220
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Greenfield, WI
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-60607
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Chicago, IL
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-63110
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: St. Louis, MO
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-67214
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Wichita, KS
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-68512
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Lincoln, NE
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-76051
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Grapevine, TX
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™ - NCT00667511-94041
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Mountain View, CA
- Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis - NCT00242164-48104
Conditions: Hemodialysis - Chronic Kidney Disease - Arrhythmia
Location: Ann Arbor, MI
- Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis - NCT00242164-48152
Conditions: Hemodialysis - Chronic Kidney Disease - Arrhythmia
Location: Livonia, MI
- Determination of Kidney Function - NCT00001978-20892
Conditions: Kidney Disease
Location: Bethesda, MD
- Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease - NCT00581269-37232
Conditions: Chronic Kidney Disease
Location: Nashville, TN
- Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function - NCT00586261-55905
Conditions: Chronic Kidney Disease
Location: Rochester, MN
- Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia - NCT01057108-80230
Conditions: Hyperphosphatemia - Chronic Kidney Disease
Location: Denver, CO
- Early Administration of Antithymocyte Globulin Followed By Cyclophosphamide, Busulfan, and Fludarabine Before a Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Kidney Cancer - NCT00787761-30342
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Atlanta, GA
- Educating Missouri Patients About Preemptive Living Donor Transplantation - NCT01048437-63110
Conditions: Chronic Kidney Disease - End Stage Renal Disease
Location: Saint Louis, MO
- Educating Missouri Patients About Preemptive Living Donor Transplantation - NCT01048437-63122
Conditions: Chronic Kidney Disease - End Stage Renal Disease
Location: Saint Louis, MO
- Educating Missouri Patients About Preemptive Living Donor Transplantation - NCT01048437-64093
Conditions: Chronic Kidney Disease - End Stage Renal Disease
Location: Warrensburg, MO
- Educating Missouri Patients About Preemptive Living Donor Transplantation - NCT01048437-65807
Conditions: Chronic Kidney Disease - End Stage Renal Disease
Location: Springfield, MO
- Educating Missouri Patients About Preemptive Living Donor Transplantation - NCT01048437-66212
Conditions: Chronic Kidney Disease - End Stage Renal Disease
Location: Overland Park, KS
- Effect of ACE-Inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease - NCT00874432-53792
Conditions: Cardiovascular Disease - Chronic Kidney Disease
Location: Madison, WI
- Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis - NCT00583973-95817
Conditions: Hemodialysis - Chronic Kidney Disease - Inflammation
Location: Sacramento, CA
- Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD) - NCT00456365-80262
Conditions: Polycystic Kidney, Autosomal Dominant
Location: Denver, CO
- Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease - NCT01012414-19107
Conditions: Coronary Artery Disease - Chronic Kidney Disease - Hypovitaminosis D - Secondary Hyperparathyroidism
Location: Philadelphia, PA
- Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study - NCT00396123-48109
Conditions: Chronic Kidney Disease - Anemia
Location: Ann Arbor, MI
- Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease - NCT00511225-68178
Conditions: End Stage Renal Disease
Location: Omaha, NE
- Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis - NCT00704483-01104
Conditions: Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
Location: Springfield, MA
- Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis - NCT00704483-02720
Conditions: Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
Location: Fall River, MA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|